These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 30260323)

  • 1. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
    Huber V; Vallacchi V; Fleming V; Hu X; Cova A; Dugo M; Shahaj E; Sulsenti R; Vergani E; Filipazzi P; De Laurentiis A; Lalli L; Di Guardo L; Patuzzo R; Vergani B; Casiraghi E; Cossa M; Gualeni A; Bollati V; Arienti F; De Braud F; Mariani L; Villa A; Altevogt P; Umansky V; Rodolfo M; Rivoltini L
    J Clin Invest; 2018 Dec; 128(12):5505-5516. PubMed ID: 30260323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma.
    Lasser S; Ozbay Kurt FG; Fritz L; Gutzeit N; De La Torre C; Altevogt P; Utikal J; Umansky V
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
    Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
    Front Immunol; 2020; 11():1214. PubMed ID: 32793185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoneutrophil Cytokine Sponges Disrupt Myeloid Expansion and Tumor Trafficking to Improve Cancer Immunotherapy.
    Li S; Wang Q; Shen Y; Hassan M; Shen J; Jiang W; Su Y; Chen J; Bai L; Zhou W; Wang Y
    Nano Lett; 2020 Jan; 20(1):242-251. PubMed ID: 31790598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
    Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
    J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
    Zhang X; Li F; Tang Y; Ren Q; Xiao B; Wan Y; Jiang S
    Oncogene; 2020 Oct; 39(40):6354-6369. PubMed ID: 32855524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
    Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T
    J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
    Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
    Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
    Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
    J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.
    Sierra RA; Trillo-Tinoco J; Mohamed E; Yu L; Achyut BR; Arbab A; Bradford JW; Osborne BA; Miele L; Rodriguez PC
    Cancer Res; 2017 Oct; 77(20):5628-5638. PubMed ID: 28904063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
    Deng Z; Rong Y; Teng Y; Zhuang X; Samykutty A; Mu J; Zhang L; Cao P; Yan J; Miller D; Zhang HG
    Oncogene; 2017 Feb; 36(5):639-651. PubMed ID: 27345402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
    Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
    FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 449c Mediates the Generation of Monocytic Myeloid-Derived Suppressor Cells by Targeting STAT6.
    Han X; Luan T; Sun Y; Yan W; Wang D; Zeng X
    Mol Cells; 2020 Sep; 43(9):793-803. PubMed ID: 32863280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors.
    Holmgaard RB; Zamarin D; Lesokhin A; Merghoub T; Wolchok JD
    EBioMedicine; 2016 Apr; 6():50-58. PubMed ID: 27211548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.
    Valencia JC; Erwin-Cohen RA; Clavijo PE; Allen C; Sanford ME; Day CP; Hess MM; Johnson M; Yin J; Fenimore JM; Bettencourt IA; Tsuneyama K; Romero ME; Klarmann KD; Jiang P; Bae HR; McVicar DW; Merlino G; Edmondson EF; Anandasabapathy N; Young HA
    Cancer Res; 2021 Dec; 81(23):5977-5990. PubMed ID: 34642183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
    Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
    Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
    Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPS expands MDSCs by inhibiting apoptosis through the regulation of the GATA2/let-7e axis.
    Yang Y; Sun D; Zhou J; Tan C; Zhang H; Chen Z; Hao C; Zhang J
    Immunol Cell Biol; 2019 Feb; 97(2):142-151. PubMed ID: 30221399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.